img

Global Virus Like Particles Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Virus Like Particles Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Virus Like Particles report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Virus Like Particles market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Vaccines and Mycoviruses are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Virus Like Particles industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Virus Like Particles key manufacturers include GlaxoSmithKline, Merck, Novavax, Takeda, Medicago, MedImmune, TechnoVax, Agilvax and Allergy Therapeutics, etc. GlaxoSmithKline, Merck, Novavax are top 3 players and held % sales share in total in 2022.
Virus Like Particles can be divided into Adeno-Associated Virus, HIV, Hepatitis B Virus and Hepatitis C Virus, etc. Adeno-Associated Virus is the mainstream product in the market, accounting for % sales share globally in 2022.
Virus Like Particles is widely used in various fields, such as Vaccines, Mycoviruses, Virus Research and Therapeutic and Imaging Agents, etc. Vaccines provides greatest supports to the Virus Like Particles industry development. In 2022, global % sales of Virus Like Particles went into Vaccines filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Virus Like Particles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Merck
Novavax
Takeda
Medicago
MedImmune
TechnoVax
Agilvax
Allergy Therapeutics
Serum Institute of India
GeoVax Labs
Cytos Biotechnology
ANGANY Genetics
CPL Biologicals
Xiamen Innovax Biotech
Segment by Type
Adeno-Associated Virus
HIV
Hepatitis B Virus
Hepatitis C Virus
Others

Segment by Application


Vaccines
Mycoviruses
Virus Research
Therapeutic and Imaging Agents
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Virus Like Particles market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Virus Like Particles, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Virus Like Particles industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Virus Like Particles in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Virus Like Particles introduction, etc. Virus Like Particles Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Virus Like Particles market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Virus Like Particles Market Overview
1.1 Virus Like Particles Product Overview
1.2 Virus Like Particles Market Segment by Type
1.2.1 Adeno-Associated Virus
1.2.2 HIV
1.2.3 Hepatitis B Virus
1.2.4 Hepatitis C Virus
1.2.5 Others
1.3 Global Virus Like Particles Market Size by Type
1.3.1 Global Virus Like Particles Market Size Overview by Type (2018-2034)
1.3.2 Global Virus Like Particles Historic Market Size Review by Type (2018-2024)
1.3.3 Global Virus Like Particles Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Virus Like Particles Sales Breakdown by Type (2018-2024)
1.4.2 Europe Virus Like Particles Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Virus Like Particles Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Virus Like Particles Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Virus Like Particles Sales Breakdown by Type (2018-2024)
2 Global Virus Like Particles Market Competition by Company
2.1 Global Top Players by Virus Like Particles Sales (2018-2024)
2.2 Global Top Players by Virus Like Particles Revenue (2018-2024)
2.3 Global Top Players by Virus Like Particles Price (2018-2024)
2.4 Global Top Manufacturers Virus Like Particles Manufacturing Base Distribution, Sales Area, Product Type
2.5 Virus Like Particles Market Competitive Situation and Trends
2.5.1 Virus Like Particles Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Virus Like Particles Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Virus Like Particles as of 2022)
2.7 Date of Key Manufacturers Enter into Virus Like Particles Market
2.8 Key Manufacturers Virus Like Particles Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Virus Like Particles Status and Outlook by Region
3.1 Global Virus Like Particles Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Virus Like Particles Historic Market Size by Region
3.2.1 Global Virus Like Particles Sales in Volume by Region (2018-2024)
3.2.2 Global Virus Like Particles Sales in Value by Region (2018-2024)
3.2.3 Global Virus Like Particles Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Virus Like Particles Forecasted Market Size by Region
3.3.1 Global Virus Like Particles Sales in Volume by Region (2024-2034)
3.3.2 Global Virus Like Particles Sales in Value by Region (2024-2034)
3.3.3 Global Virus Like Particles Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Virus Like Particles by Application
4.1 Virus Like Particles Market Segment by Application
4.1.1 Vaccines
4.1.2 Mycoviruses
4.1.3 Virus Research
4.1.4 Therapeutic and Imaging Agents
4.1.5 Others
4.2 Global Virus Like Particles Market Size by Application
4.2.1 Global Virus Like Particles Market Size Overview by Application (2018-2034)
4.2.2 Global Virus Like Particles Historic Market Size Review by Application (2018-2024)
4.2.3 Global Virus Like Particles Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Virus Like Particles Sales Breakdown by Application (2018-2024)
4.3.2 Europe Virus Like Particles Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Virus Like Particles Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Virus Like Particles Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Virus Like Particles Sales Breakdown by Application (2018-2024)
5 North America Virus Like Particles by Country
5.1 North America Virus Like Particles Historic Market Size by Country
5.1.1 North America Virus Like Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Virus Like Particles Sales in Volume by Country (2018-2024)
5.1.3 North America Virus Like Particles Sales in Value by Country (2018-2024)
5.2 North America Virus Like Particles Forecasted Market Size by Country
5.2.1 North America Virus Like Particles Sales in Volume by Country (2024-2034)
5.2.2 North America Virus Like Particles Sales in Value by Country (2024-2034)
6 Europe Virus Like Particles by Country
6.1 Europe Virus Like Particles Historic Market Size by Country
6.1.1 Europe Virus Like Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Virus Like Particles Sales in Volume by Country (2018-2024)
6.1.3 Europe Virus Like Particles Sales in Value by Country (2018-2024)
6.2 Europe Virus Like Particles Forecasted Market Size by Country
6.2.1 Europe Virus Like Particles Sales in Volume by Country (2024-2034)
6.2.2 Europe Virus Like Particles Sales in Value by Country (2024-2034)
7 Asia-Pacific Virus Like Particles by Region
7.1 Asia-Pacific Virus Like Particles Historic Market Size by Region
7.1.1 Asia-Pacific Virus Like Particles Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Virus Like Particles Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Virus Like Particles Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Virus Like Particles Forecasted Market Size by Region
7.2.1 Asia-Pacific Virus Like Particles Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Virus Like Particles Sales in Value by Region (2024-2034)
8 Latin America Virus Like Particles by Country
8.1 Latin America Virus Like Particles Historic Market Size by Country
8.1.1 Latin America Virus Like Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Virus Like Particles Sales in Volume by Country (2018-2024)
8.1.3 Latin America Virus Like Particles Sales in Value by Country (2018-2024)
8.2 Latin America Virus Like Particles Forecasted Market Size by Country
8.2.1 Latin America Virus Like Particles Sales in Volume by Country (2024-2034)
8.2.2 Latin America Virus Like Particles Sales in Value by Country (2024-2034)
9 Middle East and Africa Virus Like Particles by Country
9.1 Middle East and Africa Virus Like Particles Historic Market Size by Country
9.1.1 Middle East and Africa Virus Like Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Virus Like Particles Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Virus Like Particles Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Virus Like Particles Forecasted Market Size by Country
9.2.1 Middle East and Africa Virus Like Particles Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Virus Like Particles Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GlaxoSmithKline Virus Like Particles Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Virus Like Particles Products Offered
10.2.5 Merck Recent Development
10.3 Novavax
10.3.1 Novavax Company Information
10.3.2 Novavax Introduction and Business Overview
10.3.3 Novavax Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novavax Virus Like Particles Products Offered
10.3.5 Novavax Recent Development
10.4 Takeda
10.4.1 Takeda Company Information
10.4.2 Takeda Introduction and Business Overview
10.4.3 Takeda Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Takeda Virus Like Particles Products Offered
10.4.5 Takeda Recent Development
10.5 Medicago
10.5.1 Medicago Company Information
10.5.2 Medicago Introduction and Business Overview
10.5.3 Medicago Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Medicago Virus Like Particles Products Offered
10.5.5 Medicago Recent Development
10.6 MedImmune
10.6.1 MedImmune Company Information
10.6.2 MedImmune Introduction and Business Overview
10.6.3 MedImmune Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.6.4 MedImmune Virus Like Particles Products Offered
10.6.5 MedImmune Recent Development
10.7 TechnoVax
10.7.1 TechnoVax Company Information
10.7.2 TechnoVax Introduction and Business Overview
10.7.3 TechnoVax Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.7.4 TechnoVax Virus Like Particles Products Offered
10.7.5 TechnoVax Recent Development
10.8 Agilvax
10.8.1 Agilvax Company Information
10.8.2 Agilvax Introduction and Business Overview
10.8.3 Agilvax Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Agilvax Virus Like Particles Products Offered
10.8.5 Agilvax Recent Development
10.9 Allergy Therapeutics
10.9.1 Allergy Therapeutics Company Information
10.9.2 Allergy Therapeutics Introduction and Business Overview
10.9.3 Allergy Therapeutics Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Allergy Therapeutics Virus Like Particles Products Offered
10.9.5 Allergy Therapeutics Recent Development
10.10 Serum Institute of India
10.10.1 Serum Institute of India Company Information
10.10.2 Serum Institute of India Introduction and Business Overview
10.10.3 Serum Institute of India Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Serum Institute of India Virus Like Particles Products Offered
10.10.5 Serum Institute of India Recent Development
10.11 GeoVax Labs
10.11.1 GeoVax Labs Company Information
10.11.2 GeoVax Labs Introduction and Business Overview
10.11.3 GeoVax Labs Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.11.4 GeoVax Labs Virus Like Particles Products Offered
10.11.5 GeoVax Labs Recent Development
10.12 Cytos Biotechnology
10.12.1 Cytos Biotechnology Company Information
10.12.2 Cytos Biotechnology Introduction and Business Overview
10.12.3 Cytos Biotechnology Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Cytos Biotechnology Virus Like Particles Products Offered
10.12.5 Cytos Biotechnology Recent Development
10.13 ANGANY Genetics
10.13.1 ANGANY Genetics Company Information
10.13.2 ANGANY Genetics Introduction and Business Overview
10.13.3 ANGANY Genetics Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.13.4 ANGANY Genetics Virus Like Particles Products Offered
10.13.5 ANGANY Genetics Recent Development
10.14 CPL Biologicals
10.14.1 CPL Biologicals Company Information
10.14.2 CPL Biologicals Introduction and Business Overview
10.14.3 CPL Biologicals Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.14.4 CPL Biologicals Virus Like Particles Products Offered
10.14.5 CPL Biologicals Recent Development
10.15 Xiamen Innovax Biotech
10.15.1 Xiamen Innovax Biotech Company Information
10.15.2 Xiamen Innovax Biotech Introduction and Business Overview
10.15.3 Xiamen Innovax Biotech Virus Like Particles Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Xiamen Innovax Biotech Virus Like Particles Products Offered
10.15.5 Xiamen Innovax Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Virus Like Particles Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Virus Like Particles Industrial Chain Analysis
11.4 Virus Like Particles Market Dynamics
11.4.1 Virus Like Particles Industry Trends
11.4.2 Virus Like Particles Market Drivers
11.4.3 Virus Like Particles Market Challenges
11.4.4 Virus Like Particles Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Virus Like Particles Distributors
12.3 Virus Like Particles Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Adeno-Associated Virus
Table 2. Major Company of HIV
Table 3. Major Company of Hepatitis B Virus
Table 4. Major Company of Hepatitis C Virus
Table 5. Major Company of Others
Table 6. Global Virus Like Particles Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Virus Like Particles Sales by Type (2018-2024) & (K Dose)
Table 8. Global Virus Like Particles Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Virus Like Particles Sales by Type (2018-2024) & (US& Million)
Table 10. Global Virus Like Particles Market Share in Value by Type (2018-2024)
Table 11. Global Virus Like Particles Price by Type (2018-2024) & (USD/Dose)
Table 12. Global Virus Like Particles Sales by Type (2024-2034) & (K Dose)
Table 13. Global Virus Like Particles Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Virus Like Particles Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Virus Like Particles Sales Market Share in Value by Type (2024-2034)
Table 16. Global Virus Like Particles Price by Type (2024-2034) & (USD/Dose)
Table 17. North America Virus Like Particles Sales by Type (2018-2024) & (K Dose)
Table 18. North America Virus Like Particles Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Virus Like Particles Sales (K Dose) by Type (2018-2024)
Table 20. Europe Virus Like Particles Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Virus Like Particles Sales (K Dose) by Type (2018-2024)
Table 22. Asia-Pacific Virus Like Particles Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Virus Like Particles Sales (K Dose) by Type (2018-2024)
Table 24. Latin America Virus Like Particles Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Virus Like Particles Sales (K Dose) by Type (2018-2024)
Table 26. Middle East and Africa Virus Like Particles Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Virus Like Particles Sales by Company (2018-2024) & (K Dose)
Table 28. Global Virus Like Particles Sales Share by Company (2018-2024)
Table 29. Global Virus Like Particles Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Virus Like Particles Revenue Share by Company (2018-2024)
Table 31. Global Market Virus Like Particles Price by Company (2018-2024) & (USD/Dose)
Table 32. Global Virus Like Particles Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Virus Like Particles Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Virus Like Particles as of 2022)
Table 35. Date of Key Manufacturers Enter into Virus Like Particles Market
Table 36. Key Manufacturers Virus Like Particles Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Virus Like Particles Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Virus Like Particles Sales by Region (2018-2024) & (K Dose)
Table 40. Global Virus Like Particles Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Virus Like Particles Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Virus Like Particles Sales Market Share in Value by Region (2018-2024)
Table 43. Global Virus Like Particles Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 44. Global Virus Like Particles Sales by Region (2024-2034) & (K Dose)
Table 45. Global Virus Like Particles Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Virus Like Particles Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Virus Like Particles Sales Market Share in Value by Region (2024-2034)
Table 48. Global Virus Like Particles Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 49. Global Virus Like Particles Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Virus Like Particles Sales by Application (2018-2024) & (K Dose)
Table 51. Global Virus Like Particles Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Virus Like Particles Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Virus Like Particles Sales Market Share in Value by Application (2018-2024)
Table 54. Global Virus Like Particles Price by Application (2018-2024) & (USD/Dose)
Table 55. Global Virus Like Particles Sales by Application (2024-2034) & (K Dose)
Table 56. Global Virus Like Particles Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Virus Like Particles Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Virus Like Particles Sales Market Share in Value by Application (2024-2034)
Table 59. Global Virus Like Particles Price by Application (2024-2034) & (USD/Dose)
Table 60. North America Virus Like Particles Sales by Application (2018-2024) (K Dose)
Table 61. North America Virus Like Particles Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Virus Like Particles Sales by Application (2018-2024) (K Dose)
Table 63. Europe Virus Like Particles Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Virus Like Particles Sales by Application (2018-2024) (K Dose)
Table 65. Asia-Pacific Virus Like Particles Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Virus Like Particles Sales by Application (2018-2024) (K Dose)
Table 67. Latin America Virus Like Particles Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Virus Like Particles Sales by Application (2018-2024) (K Dose)
Table 69. Middle East and Africa Virus Like Particles Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Virus Like Particles Sales by Country (2018-2024) & (K Dose)
Table 71. North America Virus Like Particles Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Virus Like Particles Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Virus Like Particles Sales Market Share in Value by Country (2018-2024)
Table 74. North America Virus Like Particles Sales by Country (2024-2034) & (K Dose)
Table 75. North America Virus Like Particles Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Virus Like Particles Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Virus Like Particles Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Virus Like Particles Sales by Country (2018-2024) & (K Dose)
Table 79. Europe Virus Like Particles Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Virus Like Particles Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Virus Like Particles Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Virus Like Particles Sales by Country (2024-2034) & (K Dose)
Table 83. Europe Virus Like Particles Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Virus Like Particles Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Virus Like Particles Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Virus Like Particles Sales by Region (2018-2024) & (K Dose)
Table 87. Asia-Pacific Virus Like Particles Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Virus Like Particles Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Virus Like Particles Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Virus Like Particles Sales by Region (2024-2034) & (K Dose)
Table 91. Asia-Pacific Virus Like Particles Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Virus Like Particles Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Virus Like Particles Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Virus Like Particles Sales by Country (2018-2024) & (K Dose)
Table 95. Latin America Virus Like Particles Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Virus Like Particles Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Virus Like Particles Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Virus Like Particles Sales by Country (2024-2034) & (K Dose)
Table 99. Latin America Virus Like Particles Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Virus Like Particles Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Virus Like Particles Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Virus Like Particles Sales by Country (2018-2024) & (K Dose)
Table 103. Middle East and Africa Virus Like Particles Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Virus Like Particles Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Virus Like Particles Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Virus Like Particles Sales by Country (2024-2034) & (K Dose)
Table 107. Middle East and Africa Virus Like Particles Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Virus Like Particles Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Virus Like Particles Sales Market Share in Value by Country (2024-2034)
Table 110. GlaxoSmithKline Company Information
Table 111. GlaxoSmithKline Introduction and Business Overview
Table 112. GlaxoSmithKline Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 113. GlaxoSmithKline Virus Like Particles Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Merck Company Information
Table 116. Merck Introduction and Business Overview
Table 117. Merck Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 118. Merck Virus Like Particles Product
Table 119. Merck Recent Development
Table 120. Novavax Company Information
Table 121. Novavax Introduction and Business Overview
Table 122. Novavax Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 123. Novavax Virus Like Particles Product
Table 124. Novavax Recent Development
Table 125. Takeda Company Information
Table 126. Takeda Introduction and Business Overview
Table 127. Takeda Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 128. Takeda Virus Like Particles Product
Table 129. Takeda Recent Development
Table 130. Medicago Company Information
Table 131. Medicago Introduction and Business Overview
Table 132. Medicago Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 133. Medicago Virus Like Particles Product
Table 134. Medicago Recent Development
Table 135. MedImmune Company Information
Table 136. MedImmune Introduction and Business Overview
Table 137. MedImmune Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 138. MedImmune Virus Like Particles Product
Table 139. MedImmune Recent Development
Table 140. TechnoVax Company Information
Table 141. TechnoVax Introduction and Business Overview
Table 142. TechnoVax Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 143. TechnoVax Virus Like Particles Product
Table 144. TechnoVax Recent Development
Table 145. Agilvax Company Information
Table 146. Agilvax Introduction and Business Overview
Table 147. Agilvax Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 148. Agilvax Virus Like Particles Product
Table 149. Agilvax Recent Development
Table 150. Allergy Therapeutics Company Information
Table 151. Allergy Therapeutics Introduction and Business Overview
Table 152. Allergy Therapeutics Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 153. Allergy Therapeutics Virus Like Particles Product
Table 154. Allergy Therapeutics Recent Development
Table 155. Serum Institute of India Company Information
Table 156. Serum Institute of India Introduction and Business Overview
Table 157. Serum Institute of India Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 158. Serum Institute of India Virus Like Particles Product
Table 159. Serum Institute of India Recent Development
Table 160. GeoVax Labs Company Information
Table 161. GeoVax Labs Introduction and Business Overview
Table 162. GeoVax Labs Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 163. GeoVax Labs Virus Like Particles Product
Table 164. GeoVax Labs Recent Development
Table 165. Cytos Biotechnology Company Information
Table 166. Cytos Biotechnology Introduction and Business Overview
Table 167. Cytos Biotechnology Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 168. Cytos Biotechnology Virus Like Particles Product
Table 169. Cytos Biotechnology Recent Development
Table 170. ANGANY Genetics Company Information
Table 171. ANGANY Genetics Introduction and Business Overview
Table 172. ANGANY Genetics Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 173. ANGANY Genetics Virus Like Particles Product
Table 174. ANGANY Genetics Recent Development
Table 175. CPL Biologicals Company Information
Table 176. CPL Biologicals Introduction and Business Overview
Table 177. CPL Biologicals Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 178. CPL Biologicals Virus Like Particles Product
Table 179. CPL Biologicals Recent Development
Table 180. Xiamen Innovax Biotech Company Information
Table 181. Xiamen Innovax Biotech Introduction and Business Overview
Table 182. Xiamen Innovax Biotech Virus Like Particles Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 183. Xiamen Innovax Biotech Virus Like Particles Product
Table 184. Xiamen Innovax Biotech Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Virus Like Particles Market Trends
Table 188. Virus Like Particles Market Drivers
Table 189. Virus Like Particles Market Challenges
Table 190. Virus Like Particles Market Restraints
Table 191. Virus Like Particles Distributors List
Table 192. Virus Like Particles Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Virus Like Particles Product Picture
Figure 2. Global Virus Like Particles Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Virus Like Particles Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Virus Like Particles Sales Status and Outlook (2018-2034) & (K Dose)
Figure 5. Product Picture of Adeno-Associated Virus
Figure 6. Global Adeno-Associated Virus Sales YoY Growth (2018-2034) & (K Dose)
Figure 7. Product Picture of HIV
Figure 8. Global HIV Sales YoY Growth (2018-2034) & (K Dose)
Figure 9. Product Picture of Hepatitis B Virus
Figure 10. Global Hepatitis B Virus Sales YoY Growth (2018-2034) & (K Dose)
Figure 11. Product Picture of Hepatitis C Virus
Figure 12. Global Hepatitis C Virus Sales YoY Growth (2018-2034) & (K Dose)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Dose)
Figure 15. Global Virus Like Particles Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Virus Like Particles Sales Market Share by Type in 2022 & 2034
Figure 17. North America Virus Like Particles Sales Market Share in Volume by Type in 2022
Figure 18. North America Virus Like Particles Sales Market Share in Value by Type in 2022
Figure 19. Europe Virus Like Particles Sales Market Share in Volume by Type in 2022
Figure 20. Europe Virus Like Particles Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Virus Like Particles Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Virus Like Particles Sales Market Share in Value by Type in 2022
Figure 23. Latin America Virus Like Particles Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Virus Like Particles Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Virus Like Particles Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Virus Like Particles Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Virus Like Particles Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Virus Like Particles Revenue in 2022
Figure 29. Virus Like Particles Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Vaccines
Figure 31. Global Vaccines Sales YoY Growth (2018-2034) & (K Dose)
Figure 32. Product Picture of Mycoviruses
Figure 33. Global Mycoviruses Sales YoY Growth (2018-2034) & (K Dose)
Figure 34. Product Picture of Virus Research
Figure 35. Global Virus Research Sales YoY Growth (2018-2034) & (K Dose)
Figure 36. Product Picture of Therapeutic and Imaging Agents
Figure 37. Global Therapeutic and Imaging Agents Sales YoY Growth (2018-2034) & (K Dose)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Dose)
Figure 40. Global Virus Like Particles Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Virus Like Particles Sales Market Share by Application in 2022 & 2034
Figure 42. North America Virus Like Particles Sales Market Share in Volume by Application in 2022
Figure 43. North America Virus Like Particles Sales Market Share in Value by Application in 2022
Figure 44. Europe Virus Like Particles Sales Market Share in Volume by Application in 2022
Figure 45. Europe Virus Like Particles Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Virus Like Particles Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Virus Like Particles Sales Market Share in Value by Application in 2022
Figure 48. Latin America Virus Like Particles Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Virus Like Particles Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Virus Like Particles Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Virus Like Particles Manufacturing Cost Structure
Figure 53. Virus Like Particles Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries